Abstract
The toxicokinetics and biotransformation of 2,2′,3′,4,4′,5,5′-heptachlorobiphenyl, as well as its influence on the activity of microsomal and cytosolic enzymes and on the porphyrin pathway in the liver were studied in female rats following oral treatment with 7 mg/kg every other day for 3 months. One day after cessation of treatment the concentration of the compound in liver, spleen, CNS and blood was 100–500 times and in the trachea it was only 5 times less than in the adipose tissue. The daily excretion with the feces and urine amounted to 35 and 1.5 μg, respectively. In both excreta, heptachlorobiphenylol was identified as a metabolite. The biotransformation rate was estimated to be about 5%. Investigations of the liver revealed increases in the relative liver weight, total cytochrome P-450 content, O-deethylation of 7-ethoxycoumarin and in the activity of glutathione S-transferases. Disturbances of the hepatic porphyrin pathway were not detected. Only at the end of a post-dosing period of 12 months did the hepatic uroporphyrinogen decarboxylase show diminished activity. Only one of these animals with diminished enzyme activity showed drastically elevated porphyrins. In these animals, the fecal and urinary porphyrins did not differ from controls. At no time did heptachlorobiphenyl influence the urinary excretion of delta-aminolevulinic acid and porphobilinogen. The results indicate 1) that this congener shows expected toxicokinetics with the exception of being accumulated in the trachea and 2) that this congener induces disturbances of the hepatic porphyrin pathway several months after cessation of treatment.
References
Aito A (1978) A simple and sensitive assay of 7-ethoxycoumarin deethylation. Anal Biochem 85: 489–491
Ballschmiter K, Zell M (1980) Analysis of PCB by glass capillary gas-chromatography. Fresen Z Anal Chem 302: 20–31
Beck H, Mathar W (1985) Analysenverfahren zur Bestimmung von ausgewählten PCB-Einzelkomponenten in Lebensmitteln. Bundesgesundhbl 28: 1–12
Bergman A, Brandt I, Jansson B (1979) Accumulation of methylsulfonyl derivatives of some bronchial seeking polychlorinated biphenyls in the respiratory tract of mice. Toxicol Appl Pharmacol 48: 213–220
Borlakoglu JT, Walker CH (1989) Comparative aspects of congener specific PCB metabolism. Eur J Drug Metab Pharmacokmet 14: 127–131
Cadogan JIG (1962) A convenient new method of aromatic arylation. J Chem Soc: 4257–4258
Doss M, Schmidt A (1971) Quantitative Bestimmung von δ-Aminolävulinsäure and Porphobilinogen im Urin mit Ionenaustauschchromatographie-Fertigsäulen. Z Klin Chem 9: 99–102
Ferioli A, Harvey C, DeMatteis F (1984) Drug-induced accumulation of uroporphyrin in chicken hepatocyte culture: structural requirement for the effect and role of exogenous iron. Biochem J 224: 769–777
Goldstein J, Linko PC, Levy LA, McKinney JD, Gupta BN, Moore JA (1979) A comparison of a commercial polybrominated mixture, 2,4,5,2′,4′,5′,-hexabromobiphenyl and 2,3,6,7-tetrabromonaphthalene as inducers of liver microsomal drug-metabolizing enzymes. Biochem Pharmacol 28: 2947–2956
Habig WH, Pabst MJ, Jakoby WB (1974) Glutathione S-transferase. The first enzymatic step in mercapturic acid formation. J Biol Chem 249: 7130–7139
Koss G, Koransky W, Steinbach K (1976) Studies on the toxicology of hexachlorobenzene, II. Identification and determination of metabolites. Arch Toxicol 35: 107–114
Koss G, Seubert S, Seubert A, Herbert M, Koransky W, Ippen H (1980) Hexachlorobenzene and 2,4,5,2′, 4′, 5′-hexachlorobiphenyl — a comparison of their distribution, biotransformation and porphyrinogenic action in female rats. In: Holmstedt B, Lauwerys R, Mercier M, Roberfroid M (eds) Mechanisms of toxicity and hazard evaluation. Elsevier/North-Holland Biomedical Press, Amsterdam, New York, Oxford, pp 517–520
Koss G, Seubert S, Seubert A, Seidel J, Koransky W, Ippen H (1983) Studies on the toxicology of hexachlorobenzene. V. Different phases of porphyria during and after treatment. Arch Toxicol 52: 13–22
Koss G, Losekam M, Seidel J, Steinbach K, Koransky W (1987) Inhibitory effect of tetrachloro-p-hydroquinone and other metabolites of hexachlorobenzene on hepatic uroporphyrinogen decarboxylase activity with reference to the role of glutathione. Ann NY Acad Sci 514: 148–159
Lowry OH, Rosebrough NJ, Farr AL, Randall RJ (1951) Protein measurement with the Folin phenol reagent. J Biol Chem 193: 365–375
Mullin MD, Pochini CM, McCrindle S, Romkes M, Safe S, Safe LM (1984) High-resolution PCB analysis: synthesis and Chromatographic properties of all 209 PCB congeners. Environ Sci Technol 18: 468–476
Omura T, Sato R (1964) The carbon monoxide-binding pigment of liver microsomes. I. Evidence for its haemoprotein nature. J Biol Chem 239: 2370–2370
San Martin de Viale LC, Del Rios de Molina M, Wainstok de Calmanovici R, Tomio JM (1977) Porphyrins and porphyrinogen carboxy-lyase in hexachlorobenzene-induced porphyria. Biochem J 168: 393–400
Seubert A, Seubert S (1982) High-performance liquid Chromatographic analysis of porphyrins and their isomers with radial compression columns. Anal Biochem 124: 303–307
Strik JJTWA, Debets FMH, Koss G (1980) Chemical porphria. In: Kimborough R (ed) Halogenated biphenyls, terphenyls, naphthalenes, dibenzodioxins and related products. Elsevier North-Holland Biomedical Press, Amsterdam, pp 191–239
Sundström G, Wachtmeister CA (1973) Synthesis of14C-labelled and unlabelled PCB-compounds. PCB Conference II, Natl Swed Environ Protect Board 4: 73–86
Wyss PA, Mühlebach S, Bickel MM (1986) Long-term pharmacokinetics of 2,2′, 4,4′, 5,5′-hexachlorobiphenyl (6-CB) in rats with constant adipose tissue mass. Drug Metab Dispos 14: 361–365
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Koss, G., Meyer-Rogge, D., Seubert, S. et al. 2,2′,3′,4,4′,5,5′-Heptachlorobiphenyl (PCB 180) — on its toxicokinetics, biotransformation and porphyrinogenic action in female rats. Arch Toxicol 67, 651–654 (1993). https://doi.org/10.1007/BF01974073
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF01974073